Konstanze Spieth

Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology Group

Roland Kaufmann, Konstanze Spieth, Ulrike Leiter et al. · Journal of Clinical Oncology · 2005 · 120 citations

<i>In vitro</i> Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group

Selma Ugurel, Dirk Schadendorf, Claudia Pföhler et al. · Clinical Cancer Research · 2006 · 88 citations · Full text

Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial

Axel Hauschild, Michael Weichenthal, Knuth Rass et al. · Journal of Clinical Oncology · 2010 · 79 citations

Surgical Oncology, Dermatology, Immunotherapy +16

PUVA-cream photochemotherapy for the treatment of localized scleroderma

M. Grundmann-Kollmann, Falk Ochsendorf, Thomas M. Zollner et al. · Journal of the American Academy of Dermatology · 2000 · 75 citations

Ophthalmology, Systemic Scleroderma, Clinical Dermatology +4

Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study

Konstanze Spieth, Roland Kaufmann, Jens Gille · Cancer Chemotherapy and Pharmacology · 2003 · 56 citations

Pretreated Advanced Melanoma, Skin Cancer, Medicine +10